Biotia Provides Microbial Surveillance for Hospitals

On average, one in 25 people who check in to a hospital get an infection— and one in nine die of that infection. 70% of these cases are caused by antimicrobial resistance pathogens. Studies show that active pathogen surveillance and tailored interventions significantly reduce hospital-acquired infections. However, current approaches to identify pathogens, including culturing and PCR are slow, labor intensive, or limited.

Working across hospitals, we leverage next-generation DNA sequencing, and artificial intelligence, for affordable active surveillance of high risk units and high risk patients to identify and stop pathogens before patients get sick.

Workflow

 SWAB ENVIRONMENT OR PATIENTS

SWAB ENVIRONMENT OR PATIENTS

 SEQUENCE DNA

SEQUENCE DNA

 BIOTIA DATA ANALYSIS

BIOTIA DATA ANALYSIS

 PROVIDE REPORT

PROVIDE REPORT

Our Team

Biotia was founded by experts in metagenomics, bioinformatics, scientific computing and artificial intelligence, Dr. Niamh B. O'Hara, Dr. Christopher E. Mason, and Dr. Rachid Ounit. We are currently part of a business runway program at Jacobs Technion-Cornell Institute Cornell Tech.

 

Get In Touch

Please contact us with inquiries if you are interested in joining our team (as employee or intern) or would like to know more about Biotia products.